ReviewFrontiers in immunology2024
Opportunities and challenges for anti-CD47 antibodies in hematological malignancies.
Yilan Xu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
22 papers cite it
this papercites it
ReviewFrontiers in immunology2024
Yilan Xu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.